ClinicalTrials.gov
public full text
Public Domain
A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)
The purpose of this study is to evaluate the efficacy and safety of telitacicept in the treatment of moderately to severely active SLE.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus#883253
- Efficacy and Safety of Telitacicept in Early SLE#875840
- Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis#915096
- Efficacy of High-intensity Laser in Jaccoud's Arthropathy in Systemic Lupus Erythematosus#893797
- A Phase Ib Study of QLS4131 in Subjects With Systemic Lupus Erythematosus#898452
Record · ID 1362755
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive